Electrophysiology Devices Market Rising in United States | Fortune Business Insights
The global electrophysiology devices market size is projected to reach USD 9.71 billion by 2027, exhibiting a CAGR of 10.8% during the forecast period. The COVID-19 pandemic is expected to stoke the adoption of these devices owing to its close linkage with heart conditions, postulates Fortune Business Insights™ in its report, titled “Electrophysiology Devices Market Size, Share & COVID-19 Impact Analysis, Type (Ablation Catheters, Diagnostic Catheters, Mapping Systems, Accessories, and Others), By Application (Atrial Fibrillation, Supraventricular Tachycardia (SVT), Ventricular Tachycardia, and Others), By End User (Hospitals & ASCs, and Specialty Clinics & Diagnostic Centers), and Regional Forecast, 2020-2027”.
According to a research study published by the American Heart
Association (AHA), in Wuhan, the epicenter of the coronavirus pandemic, 16.7%
of the hospitalized COVID patients and 44.4% in the intensive care unit were
suffering from arrhythmias. The report from Wuhan also revealed that patients
in recovery experienced ventricular fibrillation and late myocardial
dysfunction. In July 2020, the University of Edinburgh’s survey of heart scans
of over 1,000 COVID patients from 69 countries showed that 55% of them
displayed varying degrees of heart damage and nearly 13% with no previous heart
condition developed severe cardiac disease. With heart disease being a high
risk factor for COVID-19, the demand for electrophysiology devices is set to
skyrocket during 2020.
Get Sample PDF Brochure:
https://www.fortunebusinessinsights.com/enquiry/sample/electrophysiology-devices-market-101730
|
North America |
United States, Canada and Mexico |
|
Europe |
Germany, UK, France, Italy, Russia and Turkey
etc. |
|
Asia-Pacific |
China, Japan, Korea, India, Australia, Indonesia,
Thailand, Philippines, Malaysia and Vietnam etc. |
|
South America |
Brazil, Argentina, Columbia etc. |
|
Middle East & Africa |
Saudi Arabia, UAE, Egypt, Nigeria and South
Africa |
Boston Scientific,
the leading American medical devices manufacturer, launched a first-of-its-kind
tool for monitoring the effect of radiofrequency energy delivered during
cardiac ablation procedures called DIRECTSENSE™ Technology in June 2020.
Cleared by the US Food and Drug Administration (FDA) in April, the next-gen
technology is currently the only device that can detect and monitor changes in local
electrical resistance occurring upon the application of the INTELLANAV™
ablation catheter. This will enable physicians and health workers to accurately
measure the effect of therapy during an ablation, a delicate procedure which is
conducted on the heart to eliminate heart tissue that is causing abnormal
rhythms in the heart.
Rising Instances of Product Recalls to
Impede Market Growth
Electrophysiology
devices such as pacemakers and ablation catheters are designed to prevent
adverse events in heart patients. Some of these products, however, have either
been unable to deliver the desired results or have not conformed to regulatory
norms or both, forcing companies to recall them from the market. The worrying
part is the increasing frequency of such recalls. For example, in July 2017,
the US FDA directed Sterilmed to recall its unexpired EP Ablation Cables as
they did not adhere to FDA’s premarket review and approval norms. In February
2019, Stryker voluntarily called back some of the Lifepak defibrillators in
response to reports of an issue in the devices which was causing them to
malfunction and not deliver the required therapy. A more recent incident
involved Medtronic, whose pacemaker had battery and wire defects that led to
serious side effects in patients, compelling the FDA to order the company to
recall its product in February 2020. These instances are expected to hamper the
growth of this market.
Speak To Our Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/electrophysiology-devices-market-101730
About Us:
Fortune Business Insights™ delivers accurate data and innovative
corporate analysis, helping organizations of all sizes make appropriate
decisions. We tailor novel solutions for our clients, assisting them to address
various challenges distinct to their businesses. Our aim is to empower them
with holistic market intelligence, providing a granular overview of the market
they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Comments
Post a Comment